BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25347518)

  • 1. Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus.
    Ensign LM; Lai SK; Wang YY; Yang M; Mert O; Hanes J; Cone R
    Biomacromolecules; 2014 Dec; 15(12):4403-9. PubMed ID: 25347518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.
    Yang M; Lai SK; Yu T; Wang YY; Happe C; Zhong W; Zhang M; Anonuevo A; Fridley C; Hung A; Fu J; Hanes J
    J Control Release; 2014 Oct; 192():202-8. PubMed ID: 25090196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.
    Bouchemal K; Aka-Any-Grah A; Dereuddre-Bosquet N; Martin L; Lievin-Le-Moal V; Le Grand R; Nicolas V; Gibellini D; Lembo D; Poüs C; Koffi A; Ponchel G
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2215-22. PubMed ID: 25645853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
    Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J
    Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.
    Lai SK; Wang YY; Hida K; Cone R; Hanes J
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):598-603. PubMed ID: 20018745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition.
    Schroeder HA; Nunn KL; Schaefer A; Henry CE; Lam F; Pauly MH; Whaley KJ; Zeitlin L; Humphrys MS; Ravel J; Lai SK
    Mucosal Immunol; 2018 Sep; 11(5):1477-1486. PubMed ID: 29988116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth.
    Yang M; Yu T; Wang YY; Lai SK; Zeng Q; Miao B; Tang BC; Simons BW; Ensign LM; Liu G; Chan KW; Juang CY; Mert O; Wood J; Fu J; McMahon MT; Wu TC; Hung CF; Hanes J
    Adv Healthc Mater; 2014 Jul; 3(7):1044-52. PubMed ID: 24339398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
    Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
    Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
    Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.
    Xu Q; Ensign LM; Boylan NJ; Schön A; Gong X; Yang JC; Lamb NW; Cai S; Yu T; Freire E; Hanes J
    ACS Nano; 2015 Sep; 9(9):9217-27. PubMed ID: 26301576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.
    Wang YY; Kannan A; Nunn KL; Murphy MA; Subramani DB; Moench T; Cone R; Lai SK
    Mucosal Immunol; 2014 Sep; 7(5):1036-44. PubMed ID: 24496316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo.
    Maisel K; Reddy M; Xu Q; Chattopadhyay S; Cone R; Ensign LM; Hanes J
    Nanomedicine (Lond); 2016 Jun; 11(11):1337-43. PubMed ID: 27171816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altering mucus rheology to "solidify" human mucus at the nanoscale.
    Lai SK; Wang YY; Cone R; Wirtz D; Hanes J
    PLoS One; 2009; 4(1):e4294. PubMed ID: 19173002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling.
    Sims LB; Frieboes HB; Steinbach-Rankins JM
    Int J Nanomedicine; 2018; 13():2709-2727. PubMed ID: 29760551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocrystal formulations of a poorly soluble drug. 1. In vitro characterization of stability, stabilizer adsorption and uptake in liver cells.
    Sigfridsson K; Skantze U; Skantze P; Johansson S; Grant I; Smedsrød B; Fuglesteg B; Elvevold K; Lindfors L
    Int J Pharm; 2017 Feb; 518(1-2):29-40. PubMed ID: 28012994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.
    Mert O; Lai SK; Ensign L; Yang M; Wang YY; Wood J; Hanes J
    J Control Release; 2012 Feb; 157(3):455-60. PubMed ID: 21911015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
    Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
    mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and modulation of nonoxynol-9 diffusion and bioactivity against spermatozoa in human cervical mucus.
    Dunmire EN; Katz DF
    Contraception; 1997 Feb; 55(2):115-22. PubMed ID: 9071521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
    Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.